Diagnostic and therapeutic challenges in autism spectrum disorder with comorbid bipolar disorder

Authors

  • Nirmit U. Gajjar Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India
  • Malav Patel Government Medical College, Surat, Gujarat, India
  • Ravi L. Maharaj University of the West Indies, St. Augustine, Trinidad and Tobago
  • Luis Rodriguez Universidad de Ciencias Médicas de Habana, Havana, Cuba
  • Himani J. Suthar GMERS Medical College and Civil Hospital, Gandhinagar, Gujarat, India
  • Ellie Rapp Case Western Reserve University, Cleveland, OH, USA
  • Parinda Parikh 2ND ARC Psychiatric Associates, White Plains, USA

DOI:

https://doi.org/10.18203/2320-6012.ijrms20262198

Keywords:

Autism spectrum disorder, Bipolar disorder, Comorbidity, Diagnostic overshadowing, Mania, Pharmacotherapy

Abstract

Autism spectrum disorder (ASD) is frequently associated with a variety of psychiatric comorbidities. Bipolar disorder (BD) is a mood disorder associated with ASD. The diagnosis and treatment of BD in the background of ASD presents unique difficulties in management of the patient in both diagnosis and management. Overlapping symptoms, inadequate communication of patient history and pharmacological limitations compromises treatment success. The paper discusses an adolescent male with ASD and complexities faced in diagnosing and treating secondary BD It showcases a 16 year old male with ASD with acute aggression, suicidal ideation, and severe school refusal. He was initially given a diagnosis of DMDD and GAD. His symptoms proceeded to a manic episode and a revised diagnosis of bipolar I disorder. Backed by strict parental monitoring and multidisciplinary school tracking, the patient achieved complete mood stabilization and extreme treatment compliance. The diagnostic process in the ASD-BD population is hindered by the lack of communication in history taking, masking of symptoms. Pharmacological management is complicated due to sensitivity to adverse events and limited treatment options. The comorbid ASD and BD require a highly targeted, multidisciplinary approach. There is a need for ASD specific diagnostic tools and specialized guidelines to prevent misdiagnosis and polypharmacy. The stabilization is achievable and requires tracking and tailored pharmacological strategy for optimal treatment.

References

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR. 5th ed. Washington DC: American Psychiatric Publishing. 2022.

The U.S Centers for Disease Control and Prevention (CDC). Data and Statistics on Autism Spectrum Disorder. Available at: https://www.cdc.gov/autism/data-research/index.html. Accessed on 25 April 2026.

Hughes MM, Shaw KA, Patrick ME, DiRienzo M, Bakian AV, Bilder DA, et al. Adolescents with Autism Spectrum Disorder: Diagnostic Patterns, Co-occurring Conditions, and Transition Planning. J Adolesc Health. 2023;73(2):271-8.

Zhong Y, Chen Y, Su X, Wang M, Li Q, Shao Z, Sun L. Global, regional and national burdens of bipolar disorders in adolescents and young adults: a trend analysis from 1990 to 2019. Gen Psychiatr. 2024;37(1):e101255.

Feinstein IR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 1970;23(7):455-68.

Fishbain DA. Approaches to treatment decisions for psychiatric comorbidity in the management of the chronic pain patient. Med Clin N Am. 1999;83(3):737-60.

Mosner MG, Kinard JL, Shah JS, McWeeny S, Greene RK, Lowery SC, Mazefsky CA, Dichter GS. Rates of Co-occurring Psychiatric Disorders in Autism Spectrum Disorder Using the Mini International Neuropsychiatric Interview. J Autism Dev Disord. 2019;49(9):3819-32.

Gudipati P, Narravula R, Patel D, Suthar H, Parikh P, Oza M. Misdiagnosis of autism in women for generalized anxiety disorder. Int J Res Psychiat. 2025;5(2):49-52.

Gill K, Murphy A, Zechner M, Swarbrick M, Spagnolo A. Co-Morbid Psychiatric and Medical Disorders: Challenges and Strategies. J Rehabilitat. 2009;75:32-40.

Nordgaard J, Nielsen KM, Rasmussen AR, Henriksen MG. Psychiatric comorbidity: a concept in need of a theory. Psycholl Med. 2023;53(13):5902-8.

Jessica Hellings, Andrea Witwer, Autism and Bipolar Disorder. Autism Speaks. 2026. Available at: https://www.autismspeaks.org/expert-opinion/autism-bipolar. Accessed on 25 April 2026.

Key Autism Services. Medication for autism. Available at: https://www.keyautismservices.com/blog/medication-for-autism. Accessed on 25 April 2026.

Barlattani T, D’Amelio C, Cavatassi A, De Luca D, Di Stefano R, Di Berardo A, et al. Autism spectrum disorders and psychiatric comorbidities: A narrative review. J Psychopathol. 2023;29(1-2):3-24.

Gupta N, Srinivasan S, Gupta M. Rethinking psychometric testing in autism: overcoming the challenges of comorbidity and diagnostic overshadowing. CNS Spectr. 2025;30(1):e19.

Culpepper L. The diagnosis and treatment of bipolar disorder: decision-making in primary care. Prim Care Companion CNS Disord. 2014;16(3):PCC.13r01609.

Marco EJ, Hinkley LB, Hill SS, Nagarajan SS. Sensory processing in autism: a review of neurophysiologic findings. Pediatr Res. 2011;69(5 Pt 2):48R-54R.

Mano-Sousa BJ, Pedrosa AM, Alves BC, Galduróz JCF, Belo VS, Chaves VE, et al Effects of Risperidone in Autistic Children and Young Adults: A Systematic Review and Meta-Analysis. Curr Neuropharmacol. 2021;19(4):538-52.

Blankenship K, Erickson CA, Stigler KA, Posey DJ, McDougle CJ. Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6-17 years. Ped Health. 2010;4(4):375-81.

Downloads

Published

2026-06-29

How to Cite

Gajjar, N. U., Patel, M., Maharaj, R. L., Rodriguez, L., Suthar, H. J., Rapp, E., & Parikh, P. (2026). Diagnostic and therapeutic challenges in autism spectrum disorder with comorbid bipolar disorder. International Journal of Research in Medical Sciences, 14(7), 3061–3064. https://doi.org/10.18203/2320-6012.ijrms20262198

Issue

Section

Case Reports